Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Heart Failure

  • 1
    News

    EHRs have no impact on inpatient heart failure clinical choices or outcomes

    November 15, 2021

    Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.

  • 1
    News

    BP Track: Blood pressure control rates dropped during pandemic

    November 14, 2021

    Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.

  • 1
    News

    New reports help nail down myocarditis risk with COVID-19 vaccine

    October 11, 2021

    Myocarditis linked to the two mRNA SARS-CoV-2 vaccines is rare, usually mild and self-limited, and a lot less likely than the usually more severe cases seen in COVID-19.

  • 1
    News

    Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs

    September 27, 2021

    SGLT2 inhibitor versus GLP-1 RA use was associated with a significantly lower rate of hospitalization for heart failure in people with diabetes.

  • News

    Cardiogenic shock teams again tied to lower mortality

    September 23, 2021

    New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.

  • 1
    News

    EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition

    September 20, 2021

    Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.

  • News

    COVID vaccine preprint study prompts Twitter outrage

    September 16, 2021

    The authors’ conclusions about rates of myocarditis after COVID vaccine in boys aged 12-17 years are attacked for supposedly stoking antivaccine sentiment.

  • 1
    News

    PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF

    September 14, 2021

    The SGLT2 inhibitor dapagliflozin boosted KCCQ scores and 6-minute walk distance in HFpEF patients in a 324-patient randomized trial.

  • 1
    News

    EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEF

    August 31, 2021

    The primary report from EMPEROR-Preserved on using empagliflozin to treat patients with HFpEF arrived with four other analyses published in its wake.

  • 1
    News

    Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF

    August 27, 2021

    Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies between key subgroups.

Previous1 2 3 4 … 19Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences